Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo-Cheng Huang

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Inflammation and Regeneration|February 17, 2023
A lesion-selective albumin-CTLA4Ig as a safe and effective treatment for collagen-induced arthritisFu-Yao Jiang, Yan-Zhu Zhang, Yuan-Hong Tai, et al.
International Journal of Biological Macromolecules|April 17, 2025
Protease-activated anti-Lewis Y antibody enhances selectivity and safety of glycan-targeting cancer therapyWen-Han Lee, Ying-Rou Shen, Bo-Cheng Huang, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Inflammation and Regeneration|February 17, 2023
A lesion-selective albumin-CTLA4Ig as a safe and effective treatment for collagen-induced arthritisFu-Yao Jiang, Yan-Zhu Zhang, Yuan-Hong Tai, et al.
International Journal of Biological Macromolecules|April 17, 2025
Protease-activated anti-Lewis Y antibody enhances selectivity and safety of glycan-targeting cancer therapyWen-Han Lee, Ying-Rou Shen, Bo-Cheng Huang, et al.
Pageof 3